Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS103HP in Autograft ACL Reconstruction
NCT00226772Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Jun 2005
- Primary completion
- Sep 2010
- Modality
- Large molecule
- Countries
- 2
01
Overview
A Phase 3 trial of OMS-103HP in anterior cruciate ligament injury, postoperative pain, sponsored by Omeros Corporation. Started Jun 2005; status: completed.
02
Drugs
OMS-103HP
03
Conditions
anterior cruciate ligament injurypostoperative pain
Beyond the preview
Go deeper on NCT00226772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226772.